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Abstract
Background: Ultrasound induced hyperthermia is a useful adjuvant to radiation therapy in the treatment
of prostate cancer. A uniform thermal dose (43°C for 30 minutes) is required within the targeted
cancerous volume for effective therapy. This requires specific ultrasound phased array design and
appropriate thermometry method. Inhomogeneous, acoustical, three-dimensional (3D) prostate models
and economical computational methods provide necessary tools to predict the appropriate shape of
hyperthermia phased arrays for better focusing. This research utilizes the k-space computational method
and a 3D human prostate model to design an intracavitary ultrasound probe for hyperthermia treatment
of prostate cancer. Evaluation of the probe includes ex vivo and  in vivo controlled hyperthermia
experiments using the noninvasive magnetic resonance imaging (MRI) thermometry.
Methods: A 3D acoustical prostate model was created using photographic data from the Visible Human
Project®. The k-space computational method was used on this coarse grid and inhomogeneous tissue
model to simulate the steady state pressure wavefield of the designed phased array using the linear
acoustic wave equation. To ensure the uniformity and spread of the pressure in the length of the array,
and the focusing capability in the width of the array, the equally-sized elements of the 4 × 20 elements
phased array were 1 × 14 mm. A probe was constructed according to the design in simulation using lead
zerconate titanate (PZT-8) ceramic and a Delrin® plastic housing. Noninvasive MRI thermometry and a
switching feedback controller were used to accomplish ex vivo and in vivo hyperthermia evaluations of the
probe.
Results: Both exposimetry and k-space simulation results demonstrated acceptable agreement within 9%.
With a desired temperature plateau of 43.0°C, ex vivo and in vivo controlled hyperthermia experiments
showed that the MRI temperature at the steady state was 42.9 ± 0.38°C and 43.1 ± 0.80°C, respectively,
for 20 minutes of heating.
Conclusion: Unlike conventional computational methods, the k-space method provides a powerful tool
to predict pressure wavefield in large scale, 3D, inhomogeneous and coarse grid tissue models.
Noninvasive MRI thermometry supports the efficacy of this probe and the feedback controller in an in vivo
hyperthermia treatment of canine prostate.
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Background
Prostate cancer causes approximately 30,000 deaths
among Americans every year with more than 230,000 new
patients in 2004 [1]. Most of the patients are elderly and
often can not withstand invasive surgical procedures to
eradicate the tumor in its early stages [2]. Radiation and
hormone therapies are still the treatment of choice for
these patients [3]. Thermal treatment has shown to be
effective in therapy for different kinds of tumors including
prostate cancer [4-8]. Hyperthermia therapy raises the
temperature of the tumor and a surrounding margin of
normal tissue from the normal body temperature of 37°C
to 42–45°C [9-11]. This type of treatment has had suc-
cess, in either as simultaneous or sequential adjunct to
radiation therapy, in enhancing the cytotoxic effect of the
radiation therapy [12-15]. Noninvasive ultrasound intrac-
avitary hyperthermia technology is an accepted thermal
treatment for prostate cancer [16].
Many previous simulation and design studies of intracav-
itary ultrasound phased have considered multiple layered
media but not necessarily a three-dimensional anatomical
prostate model [17-23]. Previous intracavitary ultrasound
hyperthermia phased arrays used small cylindrical radia-
tors to conform to the natural contours of large body ori-
fices [24,25]. Simulations of previous hyperthermia and
high intensity focused ultrasound (HIFU) phased arrays
were accomplished using the Rayleigh-Sommerfeld inte-
gral over a set of geometrically superimposed point
sources [26]. Homogeneous water-like media were used
to simulate pressure field distributions of these arrays [17-
20,24,25]. Such simulations, however, do not capture the
interaction of ultrasound with inhomogeneous tissue
structures. Modeling of ultrasound wave propagation in
inhomogeneous three-dimensional (3D) structure or
medium over large length scales has become feasible
using the k-space computational method [27-31]. This
method solves the spatial terms of the wave equation by
Fourier transformation to the spatial frequency domain,
while temporal iterations are performed using a non-
standard finite difference approach using the k-t space
propagator (where k  represents the spatial frequency
domain and t represents the time domain) [27]. It pro-
vides computational improvements over pseudospectral
methods, in which the spatial derivatives are evaluated
globally by Fourier transformation and wavefields are
advanced in time using second order accurate finite differ-
ences (leapfrog propagator) [32]. The k-space method
maintains its accuracy up to a Courant-Friedrichs-Lewy
number (CFL = c0Δt/Δx, where c0 is the sound speed; Δt is
the temporal step; Δx is the spatial step) of about 0.4 [27].
However, the pseudospectral method [27] rapidly
increases in error for CFL numbers above 0.1. For weak
scattering media, the k-space method provides similar
value for time steps two to three times larger than those
required by high order pseudospectral methods [27].
Compared to finite difference computations [33], in
which both spatial and temporal second order partial
derivatives are solved using second order finite difference
computations, the k-space method produces practical
results for much larger spatial step size. Equivalent accu-
racy is achieved employing only three points per mini-
mum wavelength using the k-space method compared to
14 points per minimum wavelength for the finite differ-
ence equation using the same criterion. For 3D calcula-
tions, this reduction in the spatial size reduces the storage
requirements for the k-space computations compared to
finite difference method by 98% [27].
Noninvasive magnetic resonance imaging (MRI) ther-
mometry is helpful in monitoring and controlling hyper-
thermia treatment of the prostate gland [21,34-36]. It is
important in this therapy to keep the temperature of the
healthy tissue below the targeted temperature of the can-
cerous volume. A feedback control system is useful in
maintaining the targeted tissue within the required ther-
mal dose for cytotoxicity (43°C for 30 minutes) [37]. This
research focuses on acoustical modeling of a 4 × 20 ele-
ment hyperthermia phased array, exposimetry testing,
and ex vivo and in vivo evaluation of the probe utilizing
MRI thermometry.
Methods
Phased array design and the k-space acoustic modelling
Figure 1 shows several views (xy-plane is the coronal
plane; yz-plane is the transverse or axial plane; and xz-
plane is the sagittal plane) of the 4 × 20 hyperthermia
phased array in its intracavitary housing. The array con-
sists of four segments of planar phased arrays; each seg-
ment consists of 20 elements with a 1 × 14 mm sub-
element dimension. This hyperthermia phased array ena-
bles focusing of the pressure beam in the propagation (z-
direction) and the azimuthal (y-direction) directions and
enables spreading of the focal region in the volume in
front of the array (x-direction). Electronic phasing of the
elements that make up each segment allows for steering of
the beam in the azimuth direction and adjustment of the
depth of focus in the propagation direction. The focusing
mechanisms permit varying the heating in the prostate
gland to achieve uniform thermal dose to the targeted vol-
ume. Simulation of the exact pressure wavefield in the
prostate gland requires building anatomically and acous-
tically accurate inhomogeneous human prostate model.
An anatomically and acoustically accurate 3D prostate
model was created using photographic images from the
Visible Human Project® library (U.S. National Library of
Medicine, Bethesda, MD). Figure 2 shows a transverse (yz-
plane) photographic slice of this model. It has 64 × 64
mm dimensions with a 0.25 mm grid size. The prostateBioMedical Engineering OnLine 2006, 5:56 http://www.biomedical-engineering-online.com/content/5/1/56
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gland, the rectal wall, the skeletal muscle, the fat tissue,
and the added water-like medium in the rectum are
marked and labeled in the figure. The optical parameters
that define the fractional fat, connective, glandular and
muscle soft tissues of each pixel were used to build a three-
dimensional acoustical model. The 3D photographic data
Hyperthermia phased array Figure 1
Hyperthermia phased array. Two diagrams and a photograph showing the transrectal intracavitary ultrasound probe in (a) 
coronal view (xy-plane), (b) sagittal view (xz-plane), and (c) an actual photograph of the diced hyperthermia array.BioMedical Engineering OnLine 2006, 5:56 http://www.biomedical-engineering-online.com/content/5/1/56
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permitted development of three sets of 3D acoustical data:
sound speed, density and absorption parameters[27,38].
More details of the mapping procedure are presented else-
where [39]. The prostate model was used to simulate the
pressure distribution of the hyperthermia phased array by
means of the k-space computational method.
The k-space method was used to study pressure beam for-
mation of the designed phased array through the prostate
model. The linear acoustic wave equation was used for the
simulation:
where, ∇·( ) is the spatial divergence operator; ∇( ) is the
spatial gradient operator; ρ(x, y, z) is the spatially depend-
ent density (kg/m3); c(x, y, z) is the spatially dependent
sound speed (m/s); p(x, y, z, t) is the spatially and tempo-
rally dependent pressure (Pa); α(x, y, z) is the spatially
dependent absorption coefficient (s-1, the absorption in
dB/m equals to 20 × log10(e) × α(x, y, z)/(2c0) [39]). All
absorption effects (viscous, heat conduction and internal
molecular processes losses) were represented by a single
absorption coefficient which was equivalent to the inverse
of a spatially dependent relaxation time [40]. The k-t
propagator was used to solve for the propagation in the
inhomogeneous prostate model after setting both initial
and boundary conditions [27]. The dimensions of the
model were 64 × 64 × 46 mm with 0.25 mm spatial step
size. It was composed of 257 × 257 × 185 discrete points.
The temporal step size was 0.082 μs. A tapered absorption
boundary layer, all around the model, was created to pre-
vent wave wrapping from side to side and to prevent
reflection of the waves at the boundaries. This layer is
mathematically described elsewhere [39]. A single seg-
ment of the phased array was incorporated in the acousti-
cal model for simulation purposes. Virtual elements with
1 × 14 mm dimensions were integrated in the simulation.
The established grid size of 0.25 mm for the model lim-
ited the effective kerf width (dice thickness) of the array to
this number. Each sub-element added to the overall vir-
tual source that induced pressure to the surrounding
media, depending on the acoustical parameters of each
point of the model. All points that related to a specific ele-



























The prostate model Figure 2
The prostate model. From the Visible Human Project®, a photographic image of a prostate slice shows a transverse (axial, 
yz-plane) cross section of the prostate gland.BioMedical Engineering OnLine 2006, 5:56 http://www.biomedical-engineering-online.com/content/5/1/56
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a 1.2 MHz resonance frequency and a particular phase
shift that compensated for its path length to a specific tar-
get. Greater details regarding the simulations with respect
to the design of the array are described elsewhere [29-31].
Figure 3 shows an axial two-layered gray-scale image of
both the k-space simulated normalized pressure squared
distribution and the absorption variations of the previ-
ously shown slice in Figure 2. The dimensions of the slice
are 64 × 64 mm. The white colored boundaries of the
image represent the tapered absorption layer, which pre-
vents the reflection and wrapping of the ultrasound waves
at the boundaries. The phased array is located 5 mm away
from the absorbing boundary layer. It is coupled to the
rectal wall through the water medium. The pressure
squared distribution is represented by the white colored
waves on top of the absorption gray-scale distribution.
Inhomogeneous tissue composition through the rectal
wall and the prostate gland causes irregularity of the
focused beam. The acoustic energy is focused inside the
prostate gland 40 mm away from the phased array.
Hyperthermia phased array exposimetry testing
The hyperthermia phased array system was tested using an
in-house automated exposimetry system based on the
American Institute of Ultrasound in Medicine and
National Electrical Manufacturers Association (AIUM/
NEMA) guidelines [41]. The array was submerged in an
anechoic tank (122 × 51 × 53 cm) filled with degassed dis-
tilled water. A needle-type hydrophone (precision Acous-
tics Ltd., Dorchest, UK) was placed perpendicular to the
face of the transducer to measure pressure field values at
discrete points. While focusing the acoustical energy 40
mm axially away from the face of the transducer, seven
scans were acquired in the propagation direction for a sin-
gle segment of the phased array. The average values of
these scans were compared to k-space and Rayleigh-Som-
merfeld simulation results.
Unlike k-space computations, the Rayleigh-Sommerfeld
simulations computed the pressure distribution produced
by a single segment of the phased array by summing the
pressure contributions of individual simple sources along
the extracted lines. The kerf width was 0.12 mm and the
simulations were performed in water medium without the
inclusion of the absorption term.
Figure 4 shows the normalized pressure squared of a line
that crosses the focal point in the z-direction. The mean
exposimetry results are compared to the Rayleigh-Som-
merfeld, k-space in water medium, and k-space in prostate
model simulations. The k-space simulation in the prostate
model shows that the inhomogeneous tissue structure of
the rectal wall and the prostate gland cause focusing aber-
ration and elevation of the pressure values (< -3 dB)
within the nearfield region compared to exposimetry and
other simulations. Rapid decrease in the pressure values of
the k-space prostate simulation is due to the relatively
high absorption values of this extracted axial line which
mostly composed of connective tissue with absorption
values of 110 dB/m. Both exposimetry results and k-space
water simulation results show acceptable agreement
within a 9% calculated error when comparing the -3 dB
widths of the focal volume. Rayleigh-Sommerfeld simula-
tion shows deviation of the results compared to the k-
space simulations and exposimetry results. This deviation
is due to performing the calculations of the pressure val-
ues without the inclusion of absorption effects.
MRI thermometry methods
Ex vivo and in vivo hyperthermia evaluations of the probe
were made using MRI thermometry and a switching feed-
back controller. Figure 5 shows the setup for the hyper-
thermia experiments. A personal computer used as a
switching temperature controller was connected via an
RS232 serial port to the digital power amplifier (UDS
2050PA, Advanced Surgical Systems, Inc. Tucson, AZ) and
to the console of the magnetic resonance imaging system
(3 Tesla MEDSPEC S300, Bruker BioSpin, Ettlingen, Ger-
many). The ultrasound transrectal probe was coupled to
either ex vivo bovine tissue samples (phantom) or in vivo
The k-space simulation Figure 3
The k-space simulation. A gray scaled image showing the 
simulated normalized pressure squared distribution of a sin-
gle segment of the hyperthermia phased array using the k-
space computational method. The results are shown for the 
central transverse plane of the 3D prostate model. The 
image shows a two-layered gray scale photograph for the 
central plane showing a background layer of the absorption 
distribution and the normalized squared pressure distribu-
tion on top of it while focusing axially 40 mm away from the 
face of the array.BioMedical Engineering OnLine 2006, 5:56 http://www.biomedical-engineering-online.com/content/5/1/56
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canine prostate gland using an inflated bolus of circulated
water. The transducer was connected to the driving power
amplifier. Water hoses were connected to a water pump
(Cole-Parmer Instrument Company, Barrington, IL) via a
bubble trap chamber and air hoses were connected to an
air pump. Depending on feedback temperature values, the
switching controller adjusted the driving power of each
ultrasound channel by signaling the power amplifier sys-
tem on and off. Temperature values were calculated from
the phase shift of the acquired MRI images as follows [42]:
ΔT = Δφ/(α γ TE B0)
where, ΔT is the relative temperature (°C); Δφ is the phase
difference (rad); α is the temperature dependent chemical
shift (-0.00909 ppm/°C); γ is the gyromagnetic ratio (rad/
s.T); TE is the echo time (s), and B0 is the magnetic field
(T). A spoiled gradient (SPGR) echo sequence was used to
acquire thermal images for the feedback controller. More
details are presented elsewhere [36].
For ex vivo experiments, the transrectal probe and its bolus
were held close to the bovine tissue sample and the whole
apparatus was inserted in the RF head coil and was placed
in the uniform static magnetic field and gradient coils. A
base line image was produced using these parameters: rep-
etition time TR = 100 ms, echo time TE = 15 ms, flip angle
= 30°, data matrix = 64 × 64, field of view (FOV) = 12 ×
12 cm, and slice thickness = 4 mm. The ultrasound trans-
ducer was excited for 5 minutes before acquiring another
image. Phase difference values, between base image
(before driving the transducer) and an image after five
minutes of driving the transducer, were used to calculate
temperature variations in the selected slice. The MRI-
derived average temperature of a 2 × 3 pixel region was
used as an input to the controller. In vivo animal experi-
ments were conducted with procedures approved by the
Penn State Institutional Animal Care and Use Committee
(IACUC). A mongrel-type canine (3 years old, 10 kg) was
anesthetized with Telazol (100 mg/ml, reconstituted with
Tiletamine hydrochloric acid and Zolazepam hydrochlo-
ric acid, Fort Dodge Animal Health, Fort Dodge, IA) and
was placed inside the magnet. The rectum of the dog was
manually cleaned and was filled with ultrasound gel using
a syringe. The transrectal probe was inserted in the rectum
facing the prostate gland. The vital readings of the animal
were periodically checked and recorded. MRI images were
acquired to help aligning both the prostate gland and the
phased array perpendicularly to each other. A baseline
image was produced before driving the phased array.
Another image was produced five minutes after driving
the transducer. These images were used to calculate ther-
mal distribution through the prostate gland. A smaller
region of interest (ROI) area inside the prostate was used
to average the temperature value and to feedback the con-
troller system. Each controlled hyperthermia experiment
was executed for 20 minutes.
Results
Ex vivo results
Hyperthermia controlled ex vivo experiments using MRI
thermometry were conducted for 20 minutes. Figure 6a
shows a transverse MRI image of the coupled transrectal
probe to an ex vivo bovine tissue sample with dimensions
of 100 × 70 × 4 mm. Water bolus provides good coupling
medium between the active elements of the array and the
Hyperthermia setup Figure 5
Hyperthermia setup. A sketch shows the setup of hyper-
thermia experiments using MRI thermometry.
Exposimetry results Figure 4
Exposimetry results. Normalized pressure squared distri-
bution in linear scans through the focal point in the propaga-
tion direction showing the averaged exposimetry results 
compared to conventional Rayleigh-Sommerfeld and k-space 
simulation results.BioMedical Engineering OnLine 2006, 5:56 http://www.biomedical-engineering-online.com/content/5/1/56
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tissue. Figure 6b shows the calculated relative thermal dis-
tribution after driving the transducer for five minutes. The
color bar illustrates the relative temperatures in °C. Ultra-
sound energy is concentrated 20 mm away from the face
of the transducer and is spread axially for 30 mm. Temper-
ature increases vary from 5°C to 9°C within the focal
region. The water bolus temperature is kept constant dur-
ing heating period. Figure 6c shows the results of ex vivo
controlled hyperthermia using MRI thermometry. Aiming
at 6°C relative rise, the averaged temperature of the region
of interest is raised 5.9 ± 0.38°C in 9.5 ± 0.26 minutes and
is kept till the end of the experiment. The solid continuous
line represents averaged temperature values of seven dif-
ferent experiments. The standard error bars are shown at
discrete points of 30 seconds intervals.
In vivo results
Figure 7a shows a transverse MRI image of the transrectal
probe coupled via the pressurized water bolus to a canine
prostate gland. The dimensions of this slice are 70 × 60 ×
4 mm. Water bolus provides good coupling medium
between the array and the prostate. Figure 7b shows the
calculated relative thermal image after driving the trans-
ducer for five minutes. The color bar illustrates the relative
temperatures in °C. Ultrasound energy is spread through
the prostate region. Relative temperature values vary from
3°C to 6°C within the prostate gland. Circulated water
temperature within the bolus is intended to be homoge-
neous and close to zero. However, inhomogeneous distri-
bution of temperature throughout the bolus is due to
slower flow of the pumped water. Averaged temperature
of a small ROI area of 2 × 3 pixels within the prostate
gland is used as a feedback value for the controller. Figure
7c shows the results of in vivo controlled hyperthermia.
With a desired relative temperature of 6°C, results show
that the temperature of the ROI is risen 6.1 ± 0.80°C in
6.3 minutes and is maintained approximately steady till
the end of the experiment. The solid line represents dis-
crete temperature values every 7 seconds.
Discussion
The 4 × 20 element phased array provides focusing of the
pressure wavefield within the prostate gland. The spread-
ing of the focal volume in the length of the array (the ele-
vation-direction or x-direction) is achieved by recruiting
more segments to heat the whole prostate gland.
Rayleigh-Sommerfeld and k-space simulations help in
predicting the appropriate dimensions of the array. Good
agreement between exposimetry results and the simulated
k-space results was achieved. As an example, the -3 dB dis-
tance of the focal volume in the propagation direction (z-
direction) is off by 9% between exposimetry and k-space
simulations. Hyperthermia experiments of the focused
probe were compared to a 16-element unfocused trans-
ducer [34]. With a desired relative temperature of 6°C, the
Ex vivo MRI hyperthermia Figure 6
Ex vivo MRI hyperthermia. (a) An MRI image of a selected 
bovine slice showing the focused transducer cross sectional 
view. (b) The thermal image after driving the transducer for 
five minutes. The color bar relates relative temperature val-
ues in °C. (c) Ex vivo controlled hyperthermia results using 
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controlled hyperthermia experiments show that the
steady temperature of the ROI is maintained at 6.5 ±
0.93°C and 42.8 ± 1.44°C for ex vivo and in vivo experi-
ments, respectively. Compared to unfocused transducers,
however, the focused transducer has the ability of focus-
ing acoustic energy in targeted tissue and at the same time
has the ability to steer the beam for better treatment.
Unfocused transducer spreads the energy in a fan-shaped
profile in the tissue in front of the transducer. In vivo
canine prostate hyperthermia trial proves the usefulness
of the focused probe in prostate treatment. Blood flow can
be considered a natural cooling system that works against
temperature elevation within the prostate. The tested
probes are capable of counteracting the effect of blood
cooling while keeping the targeted volume within the
required biological thermal dose.
Tissue-ultrasound interaction requires simulation of the
ultrasound perturbations produced from phased arrays
instead of summing the pressure contribution of geomet-
rically superimposed simple sources. This requirement
becomes feasible using the k-space computational
method which provides economical and accurate simula-
tion tool for large scale, coarse grid and inhomogeneous
tissue models. Simulation results of the k-space are in
good agreement with actual exposimetry results.
The 4 × 20 phased array intentionally spreads the focal
volume in the length of the array (x-direction) and allows
for varying in the width of the array (y-direction) while
changing the depth of the focusing in the axial direction
(z-direction). These variable parameters allow better ther-
mal targeting of the whole prostate gland and the seminal
vesicles. Controlling the temperature of a single point
within the targeted volume helps in delivering the
required clinical thermal dose into the targeted volume
while maintaining surrounded desired tissue. Noninva-
sive MRI thermometry is essential in monitoring and con-
trolling of thermal treatment of the prostate cancer.
Ultimately, this research has benefited from two non-
invasive technologies to help develop treatment for pros-
tate cancer in conjunction with classical therapeutic
modalities.
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